all withdrew--this isn't going to be much of a bidding war
Sentiment: Strong Sell
@itsupnowdown. A wild guess here, you're short and trying to cover. Good luck on trying to sell that one.
and add in Celgene too, they want to dominate the blood cancer market with ONXX
There are many still in that have the deep pockets to take this out at 145 to 150
sounds like Merck is in now
not sure where your getting bristol myers and gilead are out.........